TMCI
Treace John T., TMCI's CEO, spent $92.5K of their own money on 22,887 shares at $4. Their tracked buys have a 47% win rate.
+$92.5K
22,887 sh @ $4
Treace John T.
Director, Chief Executive Officer, 10% Owner, Chief Executive Offer · SEC CIK 1856380
Insider at
TMCI TREACE MEDICAL CONCEPTS, INC.
Advertisement
Buy track record
How this insider's open-market purchases have performed36%
of buys now in profit
9 up · 16 down
Avg return since buy−11.9%
Median return−8.1%
Best trade+81.5%
Worst trade−80.9%
Buys scored25
Average return by holding period — separates good entry timing from riding one long winner
After 1 month
+22.3%
88% won · 17 trades
After 3 months
+15.1%
86% won · 14 trades
After 6 months
+36.2%
93% won · 14 trades
After 12 months
−2.1%
50% won · 14 trades
| Date | Company | 90d trend | Buy price | Value | ΔOwn | 1M | 3M | 6M | 12M | To date |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | TMCI | $4 | $92.5K | +0.3% | — | — | — | — | +6.5% | |
| Jun 11, 2026 | TMCI | $4 | $40K | +0.1% | — | — | — | — | +6.5% | |
| Jun 10, 2026 | TMCI | $4 | $118.4K | +0.4% | — | — | — | — | −1.5% | |
| Jun 10, 2026 | TMCI | $4 | $59.2K | +0.2% | — | — | — | — | −1.5% | |
| Jun 1, 2026 | TMCI | $4 | $177.9K | +0.7% | — | — | — | — | +15.7% | |
| May 28, 2026 | TMCI | $3 | $184.8K | +0.8% | — | — | — | — | +35.2% | |
| May 27, 2026 | TMCI | $3 | $143.2K | +0.7% | — | — | — | — | +43.6% | |
| May 26, 2026 | TMCI | $3 | $12.6K | +0.1% | — | — | — | — | +47.2% | |
| May 14, 2026 | TMCI | $3 | $161.5K | +0.9% | +41.5% | — | — | — | +50.4% | |
| May 13, 2026 | TMCI | $2 | $120.5K | +0.7% | +54.9% | — | — | — | +64.6% | |
| May 12, 2026 | TMCI | $2 | $93.5K | +0.6% | +76.9% | — | — | — | +81.5% | |
| Mar 4, 2025 | TMCI | $9 | $524.1K | +0.9% | −12.3% | −34.7% | −18.9% | −83.4% | −52.9% | |
| Sep 16, 2024 | TMCI | $5 | $265.6K | +0.8% | +7.2% | +51.5% | +59.1% | +41.1% | −16.9% | |
| Aug 14, 2024 | TMCI | $6 | $510.3K | +1.3% | −8.4% | +39.5% | +84.3% | +27.1% | −23.9% | |
| Jun 11, 2024 | TMCI | $6 | $264.6K | +0.7% | +39.8% | −11.6% | +33.8% | +5.5% | −28.8% | |
| May 17, 2024 | TMCI | $6 | $556.2K | +1.6% | +21.6% | +27.6% | +47.4% | +34.6% | −16.7% | |
| May 14, 2024 | TMCI | $5 | $767.8K | +2.5% | +21.0% | +9.4% | +52.6% | +34.4% | −16.7% | |
| May 13, 2024 | TMCI | $5 | $683.5K | +2.5% | +32.5% | +34.0% | +74.8% | +54.1% | −8.1% | |
| May 10, 2024 | TMCI | $5 | $686.9K | +2.6% | +31.3% | +29.9% | +89.3% | +64.3% | −4.9% | |
| Nov 21, 2022 | TMCI | $22 | $327.4K | +0.3% | +10.0% | +0.6% | +23.6% | −61.0% | −80.9% | |
| Nov 17, 2022 | TMCI | $22 | $216.7K | +0.2% | +8.1% | +4.2% | +22.5% | −60.2% | −80.3% | |
| Sep 1, 2022 | TMCI | $20 | $198K | +0.2% | +15.8% | +25.1% | +6.7% | −21.0% | −78.9% | |
| Aug 26, 2022 | TMCI | $21 | $450.3K | +0.4% | +7.9% | +7.8% | +5.0% | −24.6% | −79.7% | |
| Aug 24, 2022 | TMCI | $19 | $9.6K | — | +11.4% | +11.6% | +9.9% | −22.6% | −79.1% | |
| Aug 23, 2022 | TMCI | $19 | $524.1K | +0.5% | +19.9% | +17.1% | +17.3% | −18.1% | −78.0% |
How this is calculated. We score only open-market purchases (SEC code
P) — the buys that carry real signal. Each trade's return is measured from the adjusted closing price on the purchase date to the latest close, accounting for stock splits and dividends. The 1M/3M/6M/12M columns show the same trade's return after each fixed holding period; a dash means that horizon hasn't elapsed yet or isn't priceable. Sales are excluded because insiders sell for many routine reasons. With only 25 scored trades, treat this as a small sample, not a verdict.
Advertisement
Open-market buys
$7.19M
25 trades
Open-market sells
$98.59M
27 trades
Net flow
−$91.4M
Net selling
Total filings
67
transactions shown
Full transaction history
All Form 4 activity across every company, newest firstTMCI
Treace John T., TMCI's CEO, spent $40K of their own money on 9,891 shares at $4. Their tracked buys have a 47% win rate.
+$40K
9,891 sh @ $4
TMCI
Treace John T., TMCI's CEO, spent $118.4K of their own money on 29,430 shares at $4. Their tracked buys have a 47% win rate.
+$118.4K
29,430 sh @ $4
TMCI
Treace John T., TMCI's CEO, spent $59.2K of their own money on 14,715 shares at $4. Their tracked buys have a 47% win rate.
+$59.2K
14,715 sh @ $4
TMCI
Treace John T., TMCI's CEO, spent $177.9K of their own money on 50,000 shares at $4, growing their stake 1%. Their tracked buys have a 47% win rate.
+$177.9K
50,000 sh @ $4
Advertisement
TMCI
Treace John T., TMCI's CEO, spent $184.8K of their own money on 61,202 shares at $3, growing their stake 1%. Their tracked buys have a 47% win rate.
+$184.8K
61,202 sh @ $3
TMCI
Treace John T., TMCI's CEO, spent $143.2K of their own money on 49,810 shares at $3, growing their stake 1%. Their tracked buys have a 47% win rate.
+$143.2K
49,810 sh @ $3
TMCI
Treace John T., TMCI's CEO, spent $12.6K of their own money on 4,508 shares at $3. Their tracked buys have a 47% win rate.
+$12.6K
4,508 sh @ $3
TMCI
Treace John T., TMCI's CEO, spent $161.5K of their own money on 61,750 shares at $3, growing their stake 1%. Their tracked buys have a 47% win rate.
+$161.5K
61,750 sh @ $3
TMCI
Treace John T., TMCI's CEO, spent $120.5K of their own money on 49,013 shares at $2, growing their stake 1%. Their tracked buys have a 47% win rate.
+$120.5K
49,013 sh @ $2
TMCI
Treace John T., TMCI's CEO, spent $93.5K of their own money on 43,000 shares at $2, growing their stake 1%. Their tracked buys have a 47% win rate.
+$93.5K
43,000 sh @ $2
TMCI
−$0
5,021 sh
TMCI
−$0
2,062 sh
TMCI
+$0
250,000 sh
TMCI
−$0
13,219 sh
TMCI
−$0
5,021 sh
TMCI
−$0
2,063 sh
TMCI
Treace John T., TMCI's CEO, spent $524.1K of their own money on 60,000 shares at $9, growing their stake 1%. Their tracked buys have a 47% win rate.
+$524.1K
60,000 sh @ $9
TMCI
+$0
225,000 sh
TMCI
−$0
11,905 sh
TMCI
Treace John T., TMCI's CEO, spent $265.6K of their own money on 50,000 shares at $5, growing their stake 1%. Their tracked buys have a 47% win rate.
+$265.6K
50,000 sh @ $5
TMCI
Treace John T., TMCI's CEO, spent $510.3K of their own money on 85,000 shares at $6, growing their stake 1%. Their tracked buys have a 47% win rate.
+$510.3K
85,000 sh @ $6
TMCI
Treace John T., TMCI's CEO, spent $264.6K of their own money on 45,000 shares at $6, growing their stake 1%. Their tracked buys have a 47% win rate.
+$264.6K
45,000 sh @ $6
TMCI
Treace John T., TMCI's CEO, spent $556.2K of their own money on 100,000 shares at $6, growing their stake 2%. Their tracked buys have a 47% win rate.
+$556.2K
100,000 sh @ $6
TMCI
Treace John T., TMCI's CEO, spent $767.8K of their own money on 150,000 shares at $5, growing their stake 2%. Their tracked buys have a 47% win rate.
+$767.8K
150,000 sh @ $5
TMCI
Treace John T., TMCI's CEO, spent $683.5K of their own money on 150,000 shares at $5, growing their stake 3%. Their tracked buys have a 47% win rate.
+$683.5K
150,000 sh @ $5
TMCI
Treace John T., TMCI's CEO, spent $686.9K of their own money on 150,000 shares at $5, growing their stake 3%. Their tracked buys have a 47% win rate.
+$686.9K
150,000 sh @ $5
TMCI
−$0
5,021 sh
TMCI
−$0
2,064 sh
TMCI
+$0
178,325 sh
Frequently asked questions
How is Treace John T.'s win rate calculated?
We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.
Why are some buys not included in the score?
A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.
What do the 1M / 3M / 6M / 12M columns mean?
They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.
Does a high win rate mean I should copy this insider?
No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.
Where does this data come from?
Trades come from Treace John T.'s SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.